These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
287 related items for PubMed ID: 23970168
1. Expression of lysyl oxidase in human osteosarcoma and its clinical significance: a tumor suppressive role of LOX in human osteosarcoma cells. Xu X, Wang B, Xu Y. Int J Oncol; 2013 Nov; 43(5):1578-86. PubMed ID: 23970168 [Abstract] [Full Text] [Related]
2. The overexpression of BAMBI and its involvement in the growth and invasion of human osteosarcoma cells. Zhou L, Park J, Jang KY, Park HS, Wagle S, Yang KH, Lee KB, Park BH, Kim JR. Oncol Rep; 2013 Sep; 30(3):1315-22. PubMed ID: 23807684 [Abstract] [Full Text] [Related]
3. Human breast cancer cell metastasis is attenuated by lysyl oxidase inhibitors through down-regulation of focal adhesion kinase and the paxillin-signaling pathway. Chen LC, Tu SH, Huang CS, Chen CS, Ho CT, Lin HW, Lee CH, Chang HW, Chang CH, Wu CH, Lee WS, Ho YS. Breast Cancer Res Treat; 2012 Aug; 134(3):989-1004. PubMed ID: 22434522 [Abstract] [Full Text] [Related]
9. High Expression of XRCC6 Promotes Human Osteosarcoma Cell Proliferation through the β-Catenin/Wnt Signaling Pathway and Is Associated with Poor Prognosis. Zhu B, Cheng D, Li S, Zhou S, Yang Q. Int J Mol Sci; 2016 Jul 22; 17(7):. PubMed ID: 27455247 [Abstract] [Full Text] [Related]
10. MALAT1 promotes the proliferation and metastasis of osteosarcoma cells by activating the PI3K/Akt pathway. Dong Y, Liang G, Yuan B, Yang C, Gao R, Zhou X. Tumour Biol; 2015 Mar 22; 36(3):1477-86. PubMed ID: 25431257 [Abstract] [Full Text] [Related]
11. Expression and clinical significance of HMGB1 in human liver cancer: Knockdown inhibits tumor growth and metastasis in vitro and in vivo. Dong YD, Cui L, Peng CH, Cheng DF, Han BS, Huang F. Oncol Rep; 2013 Jan 22; 29(1):87-94. PubMed ID: 23042506 [Abstract] [Full Text] [Related]
14. A molecular role for lysyl oxidase in breast cancer invasion. Kirschmann DA, Seftor EA, Fong SF, Nieva DR, Sullivan CM, Edwards EM, Sommer P, Csiszar K, Hendrix MJ. Cancer Res; 2002 Aug 01; 62(15):4478-83. PubMed ID: 12154058 [Abstract] [Full Text] [Related]
15. Active lysyl oxidase (LOX) correlates with focal adhesion kinase (FAK)/paxillin activation and migration in invasive astrocytes. Laczko R, Szauter KM, Jansen MK, Hollosi P, Muranyi M, Molnar J, Fong KS, Hinek A, Csiszar K. Neuropathol Appl Neurobiol; 2007 Dec 01; 33(6):631-43. PubMed ID: 17931358 [Abstract] [Full Text] [Related]
16. RASSF5 inhibits growth and invasion and induces apoptosis in osteosarcoma cells through activation of MST1/LATS1 signaling. Zhou XH, Yang CQ, Zhang CL, Gao Y, Yuan HB, Wang C. Oncol Rep; 2014 Oct 01; 32(4):1505-12. PubMed ID: 25109282 [Abstract] [Full Text] [Related]
18. The cyclooxygenase-2 inhibitor NS-398 inhibits proliferation and induces apoptosis in human osteosarcoma cells via downregulation of the survivin pathway. Duan DP, Dang XQ, Wang KZ, Wang YP, Zhang H, You WL. Oncol Rep; 2012 Nov 01; 28(5):1693-700. PubMed ID: 22922684 [Abstract] [Full Text] [Related]
19. The HIF-1-inducible lysyl oxidase activates HIF-1 via the Akt pathway in a positive regulation loop and synergizes with HIF-1 in promoting tumor cell growth. Pez F, Dayan F, Durivault J, Kaniewski B, Aimond G, Le Provost GS, Deux B, Clézardin P, Sommer P, Pouysségur J, Reynaud C. Cancer Res; 2011 Mar 01; 71(5):1647-57. PubMed ID: 21239473 [Abstract] [Full Text] [Related]